Olink

Olink®
Part of Thermo Fisher Scientific

Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemia

Blood Cancer Journal, 2026

Steinhäuser S., Beder T., Hübner E., Feuereisel D., Jebens J., Wolgast N., Karaca M., Richter K., Hedemann N., Steer B., Denker M., Bendig S., Brüggemann M., Silva P., Fransecky L., Neumann M., Stölzel F., Hartmann A., Gemoll T., Bastian L., Baldus C., Lipinski S.

Disease areaApplication areaSample typeProducts
Oncology
Pathophysiology
Cell Culture Supernatant
Olink Target 96

Olink Target 96

Abstract

No abstract avaialble

Read publication ↗